SG148850A1 - Methods of treating vascular disease - Google Patents
Methods of treating vascular diseaseInfo
- Publication number
- SG148850A1 SG148850A1 SG200605472-0A SG2006054720A SG148850A1 SG 148850 A1 SG148850 A1 SG 148850A1 SG 2006054720 A SG2006054720 A SG 2006054720A SG 148850 A1 SG148850 A1 SG 148850A1
- Authority
- SG
- Singapore
- Prior art keywords
- methods
- vascular disease
- treating vascular
- treating
- arteriosclerosis
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/44—Elemental carbon, e.g. charcoal, carbon black
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US35671802P | 2002-02-13 | 2002-02-13 |
Publications (1)
Publication Number | Publication Date |
---|---|
SG148850A1 true SG148850A1 (en) | 2009-01-29 |
Family
ID=27765943
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG200605472-0A SG148850A1 (en) | 2002-02-13 | 2003-02-13 | Methods of treating vascular disease |
Country Status (15)
Country | Link |
---|---|
US (2) | US7364757B2 (ja) |
EP (1) | EP1480658B1 (ja) |
JP (1) | JP2005525848A (ja) |
KR (1) | KR20040096571A (ja) |
CN (1) | CN100393323C (ja) |
AU (1) | AU2003211102B2 (ja) |
BR (1) | BRPI0307673A2 (ja) |
CA (1) | CA2475963A1 (ja) |
CO (1) | CO5611156A2 (ja) |
EA (1) | EA200401070A1 (ja) |
MX (1) | MXPA04007896A (ja) |
NO (1) | NO20034590L (ja) |
SG (1) | SG148850A1 (ja) |
UA (1) | UA86344C2 (ja) |
WO (1) | WO2003072024A2 (ja) |
Families Citing this family (37)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7678390B2 (en) | 1999-04-01 | 2010-03-16 | Yale University | Carbon monoxide as a biomarker and therapeutic agent |
GB0111872D0 (en) * | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
CN100502650C (zh) * | 2001-06-21 | 2009-06-24 | 贝思·伊斯雷尔·迪科尼斯医药中心 | 一氧化碳改善组织和器官移植结局并抑制细胞凋亡 |
US20080026984A1 (en) * | 2002-02-04 | 2008-01-31 | Alfama - Investigacao E Desenvolvimento De Productos Farmaceuticos Lda | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
US7968605B2 (en) * | 2002-02-04 | 2011-06-28 | ALFAMA—Investigação e Desenvolvimento de Produtos Farmacêuticos, Lda. | Methods for treating inflammatory disease by administering aldehydes and derivatives thereof |
EP2319518A1 (en) | 2002-02-04 | 2011-05-11 | ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. | Use of CO-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
BRPI0307673A2 (pt) * | 2002-02-13 | 2016-11-08 | Beth Israel Hospital | métodos de tratar doença vascular. |
MXPA04010243A (es) | 2002-04-15 | 2005-07-05 | Univ Pittsburgh | Metodos para tratar ileo. |
AU2003226366A1 (en) | 2002-04-15 | 2003-11-03 | Beth Israel Deaconess Medical Center | Use of heme oxygenase-1 and products of heme degradation |
WO2003088981A1 (en) | 2002-04-15 | 2003-10-30 | University Of Pittsburgh Of The Commonwealth System Of Higher Education | Methods of treating necrotizing enterocolitis |
JP4549847B2 (ja) | 2002-05-17 | 2010-09-22 | イエール ユニバーシティ | 肝炎の治療方法 |
RS105304A (en) * | 2002-06-05 | 2007-02-05 | Yale University, | Methods of treating angiogenesis,tumor growth,and metastasis |
CN1674942A (zh) * | 2002-06-21 | 2005-09-28 | 联邦高等教育系统匹兹堡大学 | 氧化氮、血红素加氧酶-1和血红素降解产物的药学用途 |
EP1558084A4 (en) * | 2002-11-07 | 2008-04-30 | Univ Pittsburgh | TREATMENT OF HEMORRHAGIC SHOCK |
GB2395432B (en) * | 2002-11-20 | 2005-09-14 | Northwick Park Inst For Medica | Therapeutic delivery of carbon monoxide to extracorporeal and isolated organs |
US20040236279A1 (en) * | 2003-05-22 | 2004-11-25 | Atrium Medical Corp. | Gaseous therapeutic agent delivery |
AU2004285477A1 (en) | 2003-10-22 | 2005-05-12 | Fred Hutchinson Cancer Research Center | Methods, compositions and devices for inducing stasis in tissues and organs |
WO2006024490A2 (en) * | 2004-08-30 | 2006-03-09 | Interstitial Therapeutics | Methods and compositions for the treatment of cell proliferation |
US7523752B2 (en) | 2005-09-21 | 2009-04-28 | Ino Therapeutics, Llc | System and method of administering a pharmaceutical gas to a patient |
US8893717B2 (en) | 2005-09-21 | 2014-11-25 | Ino Therapeutics Llc | Systems and methods of administering a pharmaceutical gas to a patient |
WO2007073226A1 (en) * | 2005-12-20 | 2007-06-28 | Alfama - Investigação E Desenvolvimento De Produtos Farmacêuticos Lda | Method for treating a mammal by administration of a compound having the ability to release co |
GB0601394D0 (en) | 2006-01-24 | 2006-03-01 | Hemocorm Ltd | Therapeutic delivery of carbon monoxide |
WO2008080128A1 (en) * | 2006-12-22 | 2008-07-03 | The Board Of Regents Of The University Of Texas System | Devices and methods for inhibiting fibrosis |
SI3498328T1 (sl) | 2009-05-27 | 2021-03-31 | Mallinckrodt Hospital Products IP Limited | Pripomoček za spajanje indeksiranega ventila in sestava posode pod tlakom s pritrdilnim obročem in za linearno sprožitev sestava sprožilnika pri odvajanju tekočin s pripomočkom za reguliranje dovajanja zdravila |
JP2011010865A (ja) | 2009-06-30 | 2011-01-20 | Ikaria Holdings Inc | 肺高血圧の臨床的または超音波心臓検査上の証拠を伴う低酸素性呼吸器不全に罹った満期産およびほぼ満期産の新生児を治療する方法 |
HUP1000243A2 (en) | 2010-05-06 | 2012-01-30 | Avidin Kft | 8-hidroxy-quinoline derivatives |
US8778413B2 (en) * | 2010-05-14 | 2014-07-15 | Ikaria, Inc. | Dosing regimens and methods of treatment using carbon monoxide |
ES2742829T3 (es) | 2011-01-14 | 2020-02-17 | Los Angeles Childrens Hospital | Solución de monóxido de carbono para el tratamiento de una enfermedad, incluida anemia de células falciformes |
ES2656237T3 (es) | 2011-04-19 | 2018-02-26 | Alfama, Inc. | Moléculas liberadoras de monóxido de carbono y usos de las mismas |
JP6134710B2 (ja) | 2011-07-21 | 2017-05-24 | アルファーマ インコーポレイテッドAlfama,Inc. | 一酸化ルテニウム放出分子およびその使用 |
EP2741821A4 (en) | 2011-08-09 | 2015-10-07 | Beth Israel Hospital | METHOD OF TREATING DNA DAMAGE |
CA2867022C (en) | 2012-03-15 | 2020-12-15 | Ino Therapeutics Llc | Methods of administering high concentrations of nitric oxide |
US20140272924A1 (en) * | 2013-03-14 | 2014-09-18 | Ganogen, Inc. | Transplantation and growth of human fetal organs in non-human animal hosts |
TW201618795A (zh) | 2014-04-15 | 2016-06-01 | 波泰里斯股份有限公司 | 用以改良器官功能及延長器官移植物壽命之系統及方法 |
JP6591203B2 (ja) * | 2015-06-01 | 2019-10-16 | キヤノンメディカルシステムズ株式会社 | 医用画像処理装置 |
CN113289074A (zh) * | 2020-02-24 | 2021-08-24 | 张建强 | 一种新型的药物涂层支架及其制备方法 |
WO2022055991A1 (en) * | 2020-09-08 | 2022-03-17 | The Brigham And Women's Hospital, Inc. | Therapeutic carbon monoxide formulations |
Family Cites Families (60)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4053590A (en) * | 1975-02-27 | 1977-10-11 | Alza Corporation | Compositions of matter comprising macromolecular hemoglobin |
US4264739A (en) * | 1979-01-05 | 1981-04-28 | Merck & Co., Inc. | Sparger for cell culture system |
JPS5679957A (en) | 1979-12-05 | 1981-06-30 | Sogo Seibutsu Igaku Kenkyusho:Kk | Erucinia enterocolitica polysaccharide sensitizing blood cell and method of detecting erucinia enterocolitica polysaccharide antibody using this |
US5240912A (en) * | 1983-05-09 | 1993-08-31 | Todaro George J | Transforming growth factor (TGF) peptides |
US4979939A (en) * | 1984-05-14 | 1990-12-25 | Surgical Systems & Instruments, Inc. | Atherectomy system with a guide wire |
US5084380A (en) * | 1985-01-29 | 1992-01-28 | Applied Biotechnology | Monoclonal antibodies reactive with activated and oncogenic ras p21 proteins |
US5449665A (en) * | 1985-09-24 | 1995-09-12 | Item Development Aktiebolag | Continuous intravenous infusion of adenosine to human patients undergoing percutaneous transluminal angioplasty |
DE3739650C1 (de) * | 1987-11-23 | 1989-05-24 | Immuno Ag | Fermenter zum Zuechten von Zellkulturen |
US5674192A (en) | 1990-12-28 | 1997-10-07 | Boston Scientific Corporation | Drug delivery |
US5180366A (en) * | 1990-10-10 | 1993-01-19 | Woods W T | Apparatus and method for angioplasty and for preventing re-stenosis |
US5792325A (en) * | 1990-11-15 | 1998-08-11 | Richardson, Jr.; William H. | Electric arc material processing system |
GB9124195D0 (en) * | 1991-11-14 | 1992-01-08 | Boc Group Plc | Connection to a gas cylinder |
US5293875A (en) * | 1992-06-16 | 1994-03-15 | Natus Medical Incorporated | In-vivo measurement of end-tidal carbon monoxide concentration apparatus and methods |
AU673057B2 (en) * | 1993-02-22 | 1996-10-24 | Abraxis Bioscience, Llc | Methods for (in vivo) delivery of biologics and compositionsuseful therefor |
AU6523194A (en) | 1993-03-26 | 1994-10-24 | Biorelease Technologies, Inc. | Compositions including heme-containing proteins and methods relating thereto |
US5523092A (en) * | 1993-04-14 | 1996-06-04 | Emory University | Device for local drug delivery and methods for using the same |
US5985307A (en) * | 1993-04-14 | 1999-11-16 | Emory University | Device and method for non-occlusive localized drug delivery |
US5763431A (en) * | 1993-08-20 | 1998-06-09 | Jackson; Meyer B. | Method for regulating neuropeptide hormone secretion |
US5588962A (en) * | 1994-03-29 | 1996-12-31 | Boston Scientific Corporation | Drug treatment of diseased sites deep within the body |
DE4421433C1 (de) * | 1994-06-18 | 1995-06-08 | Lohmann Therapie Syst Lts | Transdermales therapeutisches System mit Wirkstoffen, die Kohlenmonoxid-Quellen darstellen, Verfahren zu seiner Herstellung und seine Verwendung |
US5476764A (en) * | 1994-09-16 | 1995-12-19 | The Regents Of The University Of California | Method using CO for extending the useful shelf-life of refrigerated red blood cells |
US6066333A (en) * | 1994-09-22 | 2000-05-23 | William Harvey Research Limited | Pharmaceutical control of inflammation |
JPH0898893A (ja) * | 1994-09-29 | 1996-04-16 | Terumo Corp | 薬剤投与カテーテル |
US5664563A (en) * | 1994-12-09 | 1997-09-09 | Cardiopulmonary Corporation | Pneumatic system |
US5914316A (en) * | 1994-12-16 | 1999-06-22 | Washington University | Method of inhibiting intimal hyperplasia |
US5712293A (en) * | 1995-06-07 | 1998-01-27 | Sepracor, Inc. | Methods for treating gastro-esophageal reflux disease and other disorders associated with the digestive tract using optically pure (-) norcisapride |
JP3019366U (ja) * | 1995-06-13 | 1995-12-12 | 株式会社大東バルブ製作所 | 特定ガス用ボンベ |
FR2735382B1 (fr) * | 1995-06-15 | 1997-07-25 | Air Liquide | Installation de production de monoxyde de carbone incorporant une unite de separation cryogenique |
EP0835115B1 (en) * | 1995-06-30 | 2004-05-06 | ZymoGenetics, Inc. | 4-(2-(n-2-carboxamidoindole)aminoethyl)-benzenesulfonamides or sulfonylureas as pdgf antagonists |
DE19535781C2 (de) * | 1995-09-26 | 1999-11-11 | Fraunhofer Ges Forschung | Vorrichtung zur aktiven Strömungsunterstützung von Körperflüssigkeiten |
AU720686B2 (en) * | 1996-04-05 | 2000-06-08 | General Hospital Corporation, The | Treatment of a hemoglobinopathy |
US6069132A (en) * | 1996-08-14 | 2000-05-30 | Revanker; Ganapathi R. | Phosphazole compounds |
AU4078897A (en) * | 1996-08-23 | 1998-03-06 | Algos Pharmaceutical Corporation | Anticonvulsant containing composition for treating neuropathic pain |
WO1998008523A1 (de) | 1996-08-27 | 1998-03-05 | Messer Griesheim Gmbh | Wasserstoffhaltiges medikament |
US6315995B1 (en) | 1996-09-27 | 2001-11-13 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
US6316403B1 (en) * | 1996-09-27 | 2001-11-13 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
ATE358492T1 (de) * | 1996-09-27 | 2007-04-15 | Univ Columbia | Behandlung einer ischämischen störung und zur verbesserung des infarktergebnis |
US8128963B2 (en) * | 1996-09-27 | 2012-03-06 | The Trustees Of Columbia University In The City Of New York | Methods for treating ischemic disorders using carbon monoxide |
US6436365B2 (en) * | 1997-09-23 | 2002-08-20 | Schering Aktiengesellschaft | Process for therapeutic treatment of proliferative diseases |
US6251418B1 (en) * | 1997-12-18 | 2001-06-26 | C.R. Bard, Inc. | Systems and methods for local delivery of an agent |
TR200101503T2 (tr) | 1998-03-16 | 2002-06-21 | Celgene Corporation | 2-(2,6-dioksopiperidin-3-il) izoindolin türevleri, bunların hazırlanması ve enflamatuar sitokinlerin inhibitörleri olarak kullanımı |
US6450989B2 (en) * | 1998-04-27 | 2002-09-17 | Artemis Medical, Inc. | Dilating and support apparatus with disease inhibitors and methods for use |
JP4023919B2 (ja) * | 1998-07-21 | 2007-12-19 | 株式会社フクダ産業 | 肺機能検査装置 |
US6203991B1 (en) * | 1998-08-21 | 2001-03-20 | The Regents Of The University Of Michigan | Inhibition of smooth muscle cell migration by heme oxygenase I |
US20050250688A1 (en) * | 1999-04-01 | 2005-11-10 | The Trustees Of Columbia University In The City Of New York | Methods for treating an ischemic disorder and improving stroke outcome |
DE19932824A1 (de) * | 1999-07-14 | 2001-03-08 | Nordischer Maschinenbau | Verfahren und Vorrichtung zum Ausrichten eines toten Fisches |
JP2001082698A (ja) * | 1999-09-16 | 2001-03-30 | Teijin Ltd | 医療用酸素ボンベ |
US7632803B2 (en) * | 1999-10-01 | 2009-12-15 | Dmi Life Sciences, Inc. | Metal-binding compounds and uses therefor |
US6508784B1 (en) * | 2000-05-19 | 2003-01-21 | Yan-Ho Shu | Balloon catheter having adjustable centering capabilities and methods thereof |
FR2812197B1 (fr) | 2000-07-27 | 2003-01-03 | Air Liquide Sante Int | Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches |
FR2816212A1 (fr) * | 2000-11-03 | 2002-05-10 | Air Liquide Sante Int | Utilisation de monoxyde de carbone (co) dans le traitement des inflammations du systeme cardiovasculaire |
IL157580A0 (en) * | 2001-03-20 | 2004-03-28 | Glaxo Group Ltd | Inhalation drug combination |
CA2442457A1 (en) | 2001-03-30 | 2002-10-10 | Roland Buelow | Carbon monoxide generating compounds for treatment of vascular, inflammatory and immune disorders |
GB0111872D0 (en) | 2001-05-15 | 2001-07-04 | Northwick Park Inst For Medica | Therapeutic agents and methods |
DE60202677T2 (de) * | 2001-05-25 | 2005-12-29 | Medtronic, Inc., Minneapolis | Implantierbare medizinische vorrichtung mit kontrollierter freigabe von gasförmigen mitteln |
CN100502650C (zh) | 2001-06-21 | 2009-06-24 | 贝思·伊斯雷尔·迪科尼斯医药中心 | 一氧化碳改善组织和器官移植结局并抑制细胞凋亡 |
EP2319518A1 (en) * | 2002-02-04 | 2011-05-11 | ALFAMA-Investigacao e Desenvolvimento de Produtos Farmaceuticos Lda. | Use of CO-releasing compounds for the manufacture of a medicament for the treatment of inflammatory diseases |
BRPI0307673A2 (pt) * | 2002-02-13 | 2016-11-08 | Beth Israel Hospital | métodos de tratar doença vascular. |
AU2003226366A1 (en) * | 2002-04-15 | 2003-11-03 | Beth Israel Deaconess Medical Center | Use of heme oxygenase-1 and products of heme degradation |
DE10230165A1 (de) | 2002-07-04 | 2004-01-15 | Ino Therapeutics Gmbh | Verfahren und Vorrichtung zur Administration von Kohlenmonoxid |
-
2003
- 2003-02-13 BR BRPI0307673A patent/BRPI0307673A2/pt not_active IP Right Cessation
- 2003-02-13 WO PCT/US2003/004665 patent/WO2003072024A2/en active Application Filing
- 2003-02-13 MX MXPA04007896A patent/MXPA04007896A/es active IP Right Grant
- 2003-02-13 CA CA002475963A patent/CA2475963A1/en not_active Abandoned
- 2003-02-13 KR KR10-2004-7012581A patent/KR20040096571A/ko not_active Application Discontinuation
- 2003-02-13 CN CNB038083523A patent/CN100393323C/zh not_active Expired - Fee Related
- 2003-02-13 UA UA20040907416A patent/UA86344C2/ru unknown
- 2003-02-13 SG SG200605472-0A patent/SG148850A1/en unknown
- 2003-02-13 US US10/367,277 patent/US7364757B2/en not_active Expired - Lifetime
- 2003-02-13 EA EA200401070A patent/EA200401070A1/ru unknown
- 2003-02-13 AU AU2003211102A patent/AU2003211102B2/en not_active Ceased
- 2003-02-13 JP JP2003570771A patent/JP2005525848A/ja active Pending
- 2003-02-13 EP EP03743140.0A patent/EP1480658B1/en not_active Expired - Lifetime
- 2003-10-13 NO NO20034590A patent/NO20034590L/no not_active Application Discontinuation
-
2004
- 2004-08-30 CO CO04084713A patent/CO5611156A2/es not_active Application Discontinuation
-
2008
- 2008-03-18 US US12/050,826 patent/US7691416B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO2003072024A2 (en) | 2003-09-04 |
EP1480658B1 (en) | 2017-01-25 |
EP1480658A2 (en) | 2004-12-01 |
EP1480658A4 (en) | 2005-03-16 |
CN1646146A (zh) | 2005-07-27 |
NO20034590L (no) | 2003-12-12 |
US7364757B2 (en) | 2008-04-29 |
AU2003211102A1 (en) | 2003-09-09 |
CA2475963A1 (en) | 2003-09-04 |
CN100393323C (zh) | 2008-06-11 |
US20080167609A1 (en) | 2008-07-10 |
UA86344C2 (ru) | 2009-04-27 |
CO5611156A2 (es) | 2006-02-28 |
MXPA04007896A (es) | 2005-06-17 |
JP2005525848A (ja) | 2005-09-02 |
KR20040096571A (ko) | 2004-11-16 |
AU2003211102B2 (en) | 2010-03-04 |
NO20034590D0 (no) | 2003-10-13 |
US20030219496A1 (en) | 2003-11-27 |
WO2003072024A3 (en) | 2004-02-26 |
US7691416B2 (en) | 2010-04-06 |
BRPI0307673A2 (pt) | 2016-11-08 |
EA200401070A1 (ru) | 2005-02-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG148850A1 (en) | Methods of treating vascular disease | |
RS20050344A (en) | Treatment for hemorrhagic shock | |
MXPA05008649A (es) | Terapia de combinacion para el tratamiento de desordenes inmunoinflamatorios. | |
NO20045056L (no) | Fremgangsmater for behandling av hepatitt | |
EA200500124A1 (ru) | Способ и аппарат для введения в организм моноксида углерода | |
EP1558220A4 (en) | ORAL COMPOSITIONS FOR THE TREATMENT OF DISEASES | |
RS91004A (en) | Methods of treating ileus | |
EP1514105A4 (en) | METHOD FOR MODULATING TUBULINDEACETYLASE ACTIVITY | |
NO20045354L (no) | Fremgangsmater for behandling av angiogenese, turmorvekst og metastaser | |
RS91104A (en) | Methods of treating necrotizing enterocolitis | |
WO2005011572A3 (en) | Combination of drugs for the treatment of neoplasms | |
HK1080733A1 (en) | Pharmaceutical composition for use for the treatment of malignancies comprising in combination a bisphosphonates, a cox-2 inhibitor and a taxol | |
GB0020504D0 (en) | Therapeutic method | |
WO2004006849A3 (en) | Combinations of drugs for the treatment of neoplasms | |
TW200503666A (en) | Treatment of type 1 diabetes with pde5 inhibitors | |
TW200608965A (en) | Medicine for prevention or treatment of diabetes | |
DE60215219D1 (de) | Verwendung von darifenacin zur behandlung des harndrangs | |
MXPA05013975A (es) | Tratamiento de enfermedades asociadas con amiloide y epileptogenesis. | |
TW200501958A (en) | A therapeutic agent for treating a behavioral disorder | |
WO1998024421A3 (en) | Use of dextrin sulphate for the treatment of highly vascular tumours | |
ATE338560T1 (de) | Pharmazeutische zusammentsetzung zur medizinischen behandlung von gutartiger prostathyperplasie, dessen vorbereitungsmethode und dessen therapeutische verwendung | |
UA44238U (ru) | Способ лечения хронических сосудистых заболеваний кишечника у больных ишемической болезнью сердца и гипертонической болезнью | |
UA51365A (uk) | Спосіб лікування больового синдрому в ампутаційній куксі | |
DE60308127D1 (de) | Pharmazeutische Zusammentsetzung zur medizinischen Behandlung von gutartiger prostathyperplasie, dessen Vorbereitungsmethode und dessen therapeutische Verwendung | |
UA29668A (uk) | Спосіб локального підведення медикаментозних препаратів до зони міжкишкового анастомозу |